Literature DB >> 11388124

Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors.

R Patarca-Montero1, M Antoni, M A Fletcher, N G Klimas.   

Abstract

The literature is reviewed and data are presented that relate to a model we have developed to account for the perpetuation of the perplexing disorder currently termed chronic fatigue syndrome (CFS). In patients with CFS there is chronic lymphocyte overactivation with cytokine abnormalities that include perturbations in plasma levels of proinflammatory cytokines and decrease in the ratio of Type 1 to Type 2 cytokines produced by lymphocytes in vitro following mitogen stimulation. The initiation of the syndrome is frequently sudden and often follows an acute viral illness. Our model for the subsequent chronicity of this disorder holds that the interaction of psychological factors (distress associated with either CFS-related symptoms or other stressful life events) and the immunologic dysfunction contribute to (a) CFS-related physical symptoms (e.g., perception of fatigue and cognitive difficulties, fever, muscle and joint pain) and increases in illness burden and (b) impaired immune surveillance associated with cytotoxic lymphocytes with resulting activation of latent herpes viruses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11388124     DOI: 10.1207/S15324826AN0801_7

Source DB:  PubMed          Journal:  Appl Neuropsychol        ISSN: 0908-4282


  22 in total

1.  Immune modulation with a staphylococcal preparation in fibromyalgia/chronic fatigue syndrome: relation between antibody levels and clinical improvement.

Authors:  O Zachrisson; P Colque-Navarro; C G Gottfries; B Regland; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-20       Impact factor: 3.267

2.  A formal analysis of cytokine networks in chronic fatigue syndrome.

Authors:  Gordon Broderick; Jim Fuite; Andrea Kreitz; Suzanne D Vernon; Nancy Klimas; Mary Ann Fletcher
Journal:  Brain Behav Immun       Date:  2010-05-04       Impact factor: 7.217

3.  A Comparison of Immune Functionality in Viral versus Non-Viral CFS Subtypes.

Authors:  Nicole Porter; Athena Lerch; Leonard A Jason; Matthew Sorenson; Mary Ann Fletcher; Joshua Herrington
Journal:  J Behav Neurosci Res       Date:  2010-06-01

4.  Evidence for T-helper 2 shift and association with illness parameters in chronic fatigue syndrome (CFS).

Authors:  Susan Torres-Harding; Matthew Sorenson; Leonard A Jason; Kevin Maher; Mary Ann Fletcher
Journal:  Bull IACFS ME       Date:  2008

5.  Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome.

Authors:  Andrea T White; Alan R Light; Ronald W Hughen; Lucinda Bateman; Thomas B Martins; Harry R Hill; Kathleen C Light
Journal:  Psychophysiology       Date:  2010-03-04       Impact factor: 4.016

6.  Linking disease symptoms and subtypes with personalized systems-based phenotypes: a proof of concept study.

Authors:  Kirstin Aschbacher; Emma K Adam; Leslie J Crofford; Margaret E Kemeny; Mark A Demitrack; Amos Ben-Zvi
Journal:  Brain Behav Immun       Date:  2012-06-09       Impact factor: 7.217

Review 7.  Neuroendocrine and immune contributors to fatigue.

Authors:  Marni N Silverman; Christine M Heim; Urs M Nater; Andrea H Marques; Esther M Sternberg
Journal:  PM R       Date:  2010-05       Impact factor: 2.298

8.  Cytokine levels in CSF and neuropsychological performance in HIV patients.

Authors:  Thorsten Nolting; Antje Lindecke; Hans-Peter Hartung; Eleni Koutsilieri; Matthias Maschke; Ingo-W Husstedt; Sieghart Sopper; Olaf Stüve; Gabriele Arendt
Journal:  J Neurovirol       Date:  2012-04-12       Impact factor: 2.643

9.  High levels of type 2 cytokine-producing cells in chronic fatigue syndrome.

Authors:  A Skowera; A Cleare; D Blair; L Bevis; S C Wessely; M Peakman
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

10.  Plasma cytokines in women with chronic fatigue syndrome.

Authors:  Mary Ann Fletcher; Xiao Rong Zeng; Zachary Barnes; Silvina Levis; Nancy G Klimas
Journal:  J Transl Med       Date:  2009-11-12       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.